SWATH-Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G-CSFR Signaling

© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim Purpose: To evaluate cellular protein changes in response to treatment with an approved drug, ibrutinib, in cells expressing normal or mutated granulocyte-colony stimulating factor receptor (G-CSFR). G-CSFR mutations are associated with some he...

Full description

Saved in:
Bibliographic Details
Main Authors: Pankaj Dwivedi, Somchai Chutipongtanate, David E. Muench, Mohammad Azam, Harry Leighton Grimes, Kenneth D. Greis
Other Authors: Cincinnati Children's Hospital Medical Center
Format: Article
Published: 2020
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/57758
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University